-
1
-
-
0028031591
-
Welche Vorteile bringt eine Behandlung mit hochgereinigtem FSH bei unerfülltem Kinderwunsch? Konsensuspapier
-
Breckwoldt M, Nieschlag E, Runnebaum B, Schneider HPG. De Geyter Chr: Welche Vorteile bringt eine Behandlung mit hochgereinigtem FSH bei unerfülltem Kinderwunsch? Konsensuspapier. Zentralbl Gynakol 116 (1994) 56-57
-
(1994)
Zentralbl Gynakol
, vol.116
, pp. 56-57
-
-
Breckwoldt, M.1
Nieschlag, E.2
Runnebaum, B.3
Schneider, H.P.G.4
De Geyter, Chr.5
-
2
-
-
4344640482
-
Biological Products Derived from Human Urine
-
CPMP/118/95: London, EMEA, 26-27 April
-
CPMP/118/95: Biological Products Derived From Human Urine. CPMP Plenary Meeting, London, EMEA, 26-27 April 1995
-
(1995)
CPMP Plenary Meeting
-
-
-
3
-
-
0028923890
-
Follicle-Stimulating Hormone versus Human Menopausal Gonadotropin for in vitro Fertizilation: Results of a Meta-Analysis
-
Daya S: Follicle-Stimulating Hormone versus Human Menopausal Gonadotropin for in vitro Fertizilation: Results of a Meta-Analysis. Horm Res 43 (1995) 224-229
-
(1995)
Horm Res
, vol.43
, pp. 224-229
-
-
Daya, S.1
-
4
-
-
84961043473
-
Clinical effect of human pituitary follicle stimulating hormone (FSH)
-
Gemzell CA, et al.: Clinical effect of human pituitary follicle stimulating hormone (FSH). J Clin Endocrinol Metab 18 (1958) 1333
-
(1958)
J Clin Endocrinol Metab
, vol.18
, pp. 1333
-
-
Gemzell, C.A.1
-
5
-
-
4243177863
-
Arzneimittelforschung / Verfügbarkeit von Medikamenten. Gentechnik erhöht die Sicherheit von Vakzinen
-
3./4. 11
-
Kurth R: Arzneimittelforschung / Verfügbarkeit von Medikamenten. Gentechnik erhöht die Sicherheit von Vakzinen. Ärzte Zeitung Nr. 207, 3./4. 11. 1995 S. 18
-
(1995)
Ärzte Zeitung Nr. 207
, pp. 18
-
-
Kurth, R.1
-
6
-
-
0003075384
-
Human follicle-stimulating hormone produced by recombinant DNA technology: A review for clinicians
-
Loumaye E, Campbell R, Salat-Baroux J: Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Human Reproduction Update 1 (1995) 188-199
-
(1995)
Human Reproduction Update
, vol.1
, pp. 188-199
-
-
Loumaye, E.1
Campbell, R.2
Salat-Baroux, J.3
-
7
-
-
0028820941
-
Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization
-
Recombinant Human FSH Study Group, 1995: Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 63 (1995) 77-86
-
(1995)
Fertil Steril
, vol.63
, pp. 77-86
-
-
-
8
-
-
0029590015
-
FSH therapy: Physiological basis, new preparations and clinical use
-
in press
-
Simoni M, Nieschlag E: FSH therapy: physiological basis, new preparations and clinical use. Reprod Med Review 4 (1995) 163-177 (in press)
-
(1995)
Reprod Med Review
, vol.4
, pp. 163-177
-
-
Simoni, M.1
Nieschlag, E.2
-
9
-
-
0029619068
-
Ovarian stimulation in women undergoing in vitro fertilization and embryo transfer using recombinant human follicle-stimulating hormone (Gonal-F®) in non-down regulated cycles
-
in press
-
Strowitzki T, Kentenich H, Kiesel L, Neulen J, Bilger W: Ovarian stimulation in women undergoing in vitro fertilization and embryo transfer using recombinant human follicle-stimulating hormone (Gonal-F®) in non-down regulated cycles. Human Reproduction 1995 (in press)
-
(1995)
Human Reproduction
-
-
Strowitzki, T.1
Kentenich, H.2
Kiesel, L.3
Neulen, J.4
Bilger, W.5
-
10
-
-
4243182362
-
Low-dose recombinant human follicle-stimulating hormone therapy in World Health Organization group II anovulatory women
-
Abstract Book 2
-
Wiedemann R, Katzorke Th, Schindler A, Strowitzki Th, Temme D, Bilger W: Low-dose recombinant human follicle-stimulating hormone therapy in World Health Organization group II anovulatory women. Human Reproduction 10 (1995) Abstract Book 2
-
(1995)
Human Reproduction
, vol.10
-
-
Wiedemann, R.1
Katzorke, Th.2
Schindler, A.3
Strowitzki, Th.4
Temme, D.5
Bilger, W.6
-
11
-
-
0028003673
-
Simplification of IVF: Minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction
-
Wikiand M, Borg J, Hamberger L, Svalander P: Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Human Reproduction 9 (1994) 1430-1436
-
(1994)
Human Reproduction
, vol.9
, pp. 1430-1436
-
-
Wikiand, M.1
Borg, J.2
Hamberger, L.3
Svalander, P.4
|